Live Breaking News & Updates on More Such Health News

Stay updated with breaking news from More such health news. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes

(RTTNews) - The US Food and Drug Administration AstraZeneca s Farxiga (dapagliflozin) to improve glycemic control in pediatric patients with type-. ....

Drug Administration Astrazeneca Farxiga , More Such Health News , Drug Administration Astrazeneca ,

Genmab's Phase 2 Data: Acasunlimab Combination Shows Promise In Metastatic NSCLC

(RTTNews) - Genmab A/S (GMAB) and BioNTech SE (BNTX) announced initial data from the ongoing Phase 2 trial of acasunlimab in combination with pemb. ....

More Such Health News ,

Lilly Announces Updated Data From Phase 1/2 Study Of Olomorasib In Advanced Solid Tumors

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS G12C-mutant advanced solid ....

Timothy Burns , Eli Lilly , More Such Health News , Associate Professor , Pittsburgh Medical Center Hillman Cancer , Ihr Portfolio ,

Gilead: Phase 3 Study Of Trodelvy In Metastatic Urothelial Cancer Fails To Meet Primary Endpoint

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said that the confirmatory Phase 3 TROPiCS-04 study of Trodelvy in locally advanced or metastatic urothelial cancer did not meet the primary ....

More Such Health News , Gilead Sciences Inc , Boxed Warning , Ihr Portfolio ,

Novartis: Phase III Data On Oral Remibrutinib Shows Long-Term Efficacy & Safety In Chronic Urticaria

BASEL (dpa-AFX) - Novartis (NVS) announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective Bruton's tyrosine kinase (BTK) inhibitor, in chronic spontaneous ....

More Such Health News , Ihr Portfolio ,